Covid Treatments
-
{
- All
- News
-
High-Dose Covid Treatment Less Effective In India Than Europe: Study
A higher dose of the COVID-19 drug, dexamethasone, may have less beneficial effects for patients in India as compared with those in Europe, according to a study published in The Lancet Regional Health - Southeast Asia journal.
-
Delhi Government To Reimburse Rs 16 Lakh Covid Expense To Judicial Officer
The Delhi High Court has directed the Delhi government to reimburse forthwith over Rs 16 lakh to a serving judge of the district judiciary towards the cost of Covid treatment.
-
WHO "Strongly" Advises Against Use Of 2 Covid Antibody Treatments: Report
Two COVID-19 antibody treatments are no longer recommended by the World Health Organisation because Omicron and its subvariants have likely rendered them obsolete, according to a revised guideline published in the British Medical Journal.
-
Coronavirus: What Is The Impact Of The BA.5 Variant?
Almost as a silver-lining (if one could call it that), the symptoms of COVID-19 induced by BA.5 are largely mild, especially in vaccinated individuals.
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
WHO Approves Two New Treatments For Coronavirus, Including Arthritis Drug
The World Health Organization approved two new Covid-19 treatments on Friday, growing the arsenal of tools along with vaccines to stave off severe illness and death from the virus.
-
8.3 Lakh Covid Cases Treated Under Ayushman Bharat In 2 years: Centre
Approximately 8.3 lakh hospital admissions were authorised for the treatment of COVID-19 under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) in the last two years, the Rajya Sabha was informed on Tuesday.
-
Pfizer Says Its Antiviral Pill Cuts Risk Of Severe Covid By 89%
A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease.
-
Top Medical Body Drops Ivermectin, Hydroxychloroquine From Covid Treatment
Indian Council of Medical Research (ICMR)-COVID-19 National Task Force Joint Monitoring Group dropped the usage of Ivermectin and Hydroxychloroquine (HCQ) drugs from revised clinical guidelines for the management of adult COVID-19 patients.
-
Ivermectin, HCQ Dropped From One Covid Treatment List, Kept On Another
The Union health ministry has issued revised guidelines for management of Covid-infected patients, dropping many sought-after drugs like ivermectin, hydroxychloroquine and anti-viral Favipiravir from Covid treatment.
-
Delhi High Court Dismisses Plea Seeking Change In Covid Treatment Protocol
The Delhi High Court today dismissed with cost of Rs 25,000 a petition seeking change of the existing protocol for treating COVID-19 patients, saying the course of treatment was not fixed on some "ipse dixit" (unproven statement).
-
US Drugmaker To Donate 400,000 Covid Treatment Tablets To India
Eli Lilly and Co said on Tuesday it would supply 400,000 tablets of its COVID-19 treatment, to be used with Gilead's remdesivir, to India as the country fights a raging pandemic that has morgues and hospitals overflowing.
-
14 Delhi Hospitals Turned Into Covid-Exclusive Centres. Here's The List
The Delhi government on Monday said 14 private hospitals in the city have been made "full COVID-19" hospitals and asked them not to admit patients other than those infected with coronavirus.
-
Will Fix Rates For Covid Treatment In State's Private Hospitals: Shivraj Chouhan
Amid reports that private hospitals are overcharging COVID-19 patients, Madhya Pradesh Chief Minister Shivraj Singh Chouhan on Tuesday said the state government will cap the rates of the treatment for patients.
-
High-Dose Covid Treatment Less Effective In India Than Europe: Study
A higher dose of the COVID-19 drug, dexamethasone, may have less beneficial effects for patients in India as compared with those in Europe, according to a study published in The Lancet Regional Health - Southeast Asia journal.
-
Delhi Government To Reimburse Rs 16 Lakh Covid Expense To Judicial Officer
The Delhi High Court has directed the Delhi government to reimburse forthwith over Rs 16 lakh to a serving judge of the district judiciary towards the cost of Covid treatment.
-
WHO "Strongly" Advises Against Use Of 2 Covid Antibody Treatments: Report
Two COVID-19 antibody treatments are no longer recommended by the World Health Organisation because Omicron and its subvariants have likely rendered them obsolete, according to a revised guideline published in the British Medical Journal.
-
Coronavirus: What Is The Impact Of The BA.5 Variant?
Almost as a silver-lining (if one could call it that), the symptoms of COVID-19 induced by BA.5 are largely mild, especially in vaccinated individuals.
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
WHO Approves Two New Treatments For Coronavirus, Including Arthritis Drug
The World Health Organization approved two new Covid-19 treatments on Friday, growing the arsenal of tools along with vaccines to stave off severe illness and death from the virus.
-
8.3 Lakh Covid Cases Treated Under Ayushman Bharat In 2 years: Centre
Approximately 8.3 lakh hospital admissions were authorised for the treatment of COVID-19 under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) in the last two years, the Rajya Sabha was informed on Tuesday.
-
Pfizer Says Its Antiviral Pill Cuts Risk Of Severe Covid By 89%
A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease.
-
Top Medical Body Drops Ivermectin, Hydroxychloroquine From Covid Treatment
Indian Council of Medical Research (ICMR)-COVID-19 National Task Force Joint Monitoring Group dropped the usage of Ivermectin and Hydroxychloroquine (HCQ) drugs from revised clinical guidelines for the management of adult COVID-19 patients.
-
Ivermectin, HCQ Dropped From One Covid Treatment List, Kept On Another
The Union health ministry has issued revised guidelines for management of Covid-infected patients, dropping many sought-after drugs like ivermectin, hydroxychloroquine and anti-viral Favipiravir from Covid treatment.
-
Delhi High Court Dismisses Plea Seeking Change In Covid Treatment Protocol
The Delhi High Court today dismissed with cost of Rs 25,000 a petition seeking change of the existing protocol for treating COVID-19 patients, saying the course of treatment was not fixed on some "ipse dixit" (unproven statement).
-
US Drugmaker To Donate 400,000 Covid Treatment Tablets To India
Eli Lilly and Co said on Tuesday it would supply 400,000 tablets of its COVID-19 treatment, to be used with Gilead's remdesivir, to India as the country fights a raging pandemic that has morgues and hospitals overflowing.
-
14 Delhi Hospitals Turned Into Covid-Exclusive Centres. Here's The List
The Delhi government on Monday said 14 private hospitals in the city have been made "full COVID-19" hospitals and asked them not to admit patients other than those infected with coronavirus.
-
Will Fix Rates For Covid Treatment In State's Private Hospitals: Shivraj Chouhan
Amid reports that private hospitals are overcharging COVID-19 patients, Madhya Pradesh Chief Minister Shivraj Singh Chouhan on Tuesday said the state government will cap the rates of the treatment for patients.
